Abstract:Objective: Qingfei oral liquid (QF), an experimental Chinese medicine prescription developed from the ancient priscription of traditional Chinese medicines Ma Xin Shi Gan decoction and Tingli Dazao Xie Fei decoction, has been effectively used since decades to treat patients with viral pneumonia and asthma. In our previous study, we had demonstrated that QF can significantly reduce airway hyperresponsiveness, hyperemia, lung tissue edema, inflammatory lung tissue infiltration in mice, airway mucus secretion, and peripheral airway collagen hyperplasia; however, its mechanism of action is unknown. Methods: Fifty 6-8-week-old male BALB/c mice were equally and randomly divided into five groups: the control, ovalbumin (OVA), OVA + respiratory syncytial virus (RSV), QF, and dexamethasone (Dxms) groups. The QF group was administered QF at 1.17 g.kg(-1).d(-1), the Dxms group received dexamethasone injections at 0.2 mg.kg(-1).d(-1), and the remaining groups were administered PBS. Inflammation in the lung tissue was assessed by hematoxylin and eosin (HE), periodic acid-Schiff (PAS), and Van Gieson staining. ELISA was used to evaluate the IL-13, IL-25, and IL-33 in the mice. Western blotting was used to examine changes in the proteins levels of transient receptor potential vanilloid-1 (TRPV1) and mucin 5AC (MUC5AC) in the lung tissues of mice. Results: Histopathological evaluation revealed that the OVA and OVA + RSV groups exhibited lung tissue edema and inflammatory lung tissue infiltration in the HE staining and airway secretions in the PAS staining; collagen hyperplasia around the airway was increased in these two groups compared with the control group. The QF group exhibited significantly reduced lung tissue edema, inflammatory lung tissue infiltration, airway secretions, and collagen hyperplasia around the airway compared with the OVA + RSV group. We analyzed the serum levels of IL-13, IL-25, and IL-33 in the mice and found that these levels were higher in the OVA and OVA + RSV groups than in the control group (P < 0.05 in the OVA group, P < 0.01 in the OVA + RSV group). The QF group exhibited significantly decreased serum levels of IL-13, IL-25, and IL-33 compared with the OVA + RSV group (all P < 0.05). The Dxms group also exhibited significant decreases in the serum levels of IL-13 and IL-33 (all P < 0.05) but no significant decrease in the serum levels of IL-25 compared with the RSV + OVA group. Finally, we examined the protein levels of TRPV1 and MUC5AC in the lung tissues of mice using Western blotting. After identifying RSV infection in the mice with asthma, the protein levels of TRPV1 and MUC5AC in the lung tissues of mice were significantly higher than those in the control group (P < 0.05, P < 0.01). We found that compared with RSV + OVA, QF can significantly downregulate the protein level of TRPV1; further, the protein level of MUC5AC was also significantly reduced (all P < 0.001). Conclusion: QF can inhibit RSV replication and reduce airway inflammation and mucus hypersecretion injury caused by RSV infection and asthma, and its mechanism of action may be associated with the downregulation of TRPV1 expression and a decrease in airway mucus hypersecretion injury.

Mechanism of Qingfei Oral Liquid to Regulate Respiratory Inflammatory Damage Caused by RSV via ERK1/2 Pathway

Qingfei Oral Liquid alleviates airway inflammation in RSV-infected asthmatic mice

Qingfei Oral Liquid Inhibited Autophagy to Alleviate Inflammation Via Mtor Signaling Pathway in RSV-infected Asthmatic Mice

Integrated Network Pharmacology and Lipidomics to Reveal the Inhibitory Effect of Qingfei Oral Liquid on Excessive Autophagy in RSV-Induced Lung Inflammation

Qingfei Oral Liquid Alleviates Airway Hyperresponsiveness and Mucus Hypersecretion Via TRPV1 Signaling in RSV-infected Asthmatic Mice.

Qingfei Oral Liquid Downregulates TRPV1 Expression to Reduce Airway Inflammation and Mucus Hypersecretion Injury Caused by Respiratory Syncytial Virus Infection and Asthma in Mice

Study on mechanism of antiviral effects on RSV of Xiaoer Shuangjin Qingre Oral Liquid

Effect of Xiaoer Shuangjin Qingre Oral Liquid on Serum Inflammatory Factors of Mice Infected by Respiratory Syncytial Virus

Label-free Quantitative Proteomics Reveals Fibrinopeptide B and Heparin Cofactor II As Potential Serum Biomarkers in Respiratory Syncytial Virus-Infected Mice Treated with Qingfei Oral Liquid Formula.

Network pharmacology, molecular docking, and untargeted metabolomics reveal molecular mechanisms of multi-targets effects of Qingfei Tongluo Plaster improving respiratory syncytial virus pneumonia

Quercetin induces itaconic acid-mediated M1/M2 alveolar macrophages polarization in respiratory syncytial virus infection

Investigating the active components and mechanistic effects of Forsythia suspensa Leaf against RSV via the PI3K/Akt-NLRP3 pathway

Anti-inflammatory activities of Qingfei oral liquid and its influence on respiratory microbiota in mice with ovalbumin-induced asthma

Integrating metabolomics and network pharmacology to assess the effects of quercetin on lung inflammatory injury induced by human respiratory syncytial virus

Pratensein glycoside attenuates respiratory syncytial virus infection-induced oxidative and inflammatory injury via TGF-β signaling pathway

Xuanfei Formula inhibited RSV infection by normalizing the SREBP2-mediated cholesterol synthesis process

Study on antiviral effect of Xiaoer Shuangjin Qingre Oral Liquid in vitro

Resveratrol inhibits respiratory syncytial virus replication by targeting heparan sulfate proteoglycan

Primary study of MAPK signal transduction pathway in lung of respiratory syncytial virus infected SD rat

An experimental study on anti-respiratory syncytial virus with xiasangju extract

Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium